Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Matthew Arnold
Email Matthew Arnold
Recent Articles
Indian conglomerate buys Manhattan Research parent for $635m
May 16, 2012
A Mumbai-based pharma custom manufacturing firm is buying the parent company of Manhattan Research.
Sales forces shrank in 2011, but not everywhere
May 16, 2012
Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn't shared evenly between the biggest of pharmas, as a number of players scaled up.
Coach vs. cancer in BMS-backed awareness effort
May 15, 2012
Former Steelers coach Bill Cowher is fronting a Bristol-Myers Squibb-backed Melanoma Exposed awareness campaign.
Saatchi shop rebrands to sharpen specialty focus
May 08, 2012
Saatchi & Saatchi Innovations, Publicis' Pennsylvania-based outpost servicing specialty pharma, is rebranding as Saatchi Science.
Docs trust ED drugs above all, go with their emotions when prescribing
May 08, 2012
Viagra and Cialis took top honors for most trusted pharmaceutical brands in a poll of physicians.
Pfizer, Crestor tops for global promotional spend in 2011
May 01, 2012
Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.
Online doc quiz mixes CME, gaming
May 01, 2012
Could an online quiz be the future of continuing medical education?
Davenport is named new Sermo CEO
May 01, 2012
Sermo has named former Revolution Health president Tim Davenport CEO.
Digital Media briefs: May 2012
May 01, 2012
News on HealthiNation, thebump.com, Medscape Mobile, Ignite Health
LLNS appoints Hamburg as CCO
May 01, 2012
LLNS named Steve Hamburg chief creative officer.
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
Makers of pain pills, advocacy groups at center of Senate probe
Saatchi shop rebrands to sharpen specialty focus
RX-to-OTC proposal gets mixed reviews
Roche ends dalcetrapib trial, questions linger on CETP class
Docs trust ED drugs above all, go with their emotions when prescribing
Nurses get their own app with Lippincott launch
Harvard urges faculty to ditch journals
Massachusetts gift ban under attack (again)
Enbrel reps risk layoff, as Pfizer calls early end to US selling
Pharma Report 2012: Get Back in Shape
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Pfizer, Crestor tops for global promotional spend in 2011
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Med Ed Report: Show Me the Money
Bydureon catching on among endos but low profits expected, Amylin says
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Sales forces shrank in 2011, but not everywhere
National plan seeks Alzheimer's treatment by 2025
Coach vs. cancer in BMS-backed awareness effort
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Siding with Lilly, appeals court overturns decision in rep overtime case
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Popular Topics
Acquisition
Adherence
Agency
App
Conflict Of Interest
Digital
Direct To Consumer (DTC)
Downsize
Education & Awareness
FDA
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Mobile
Obesity
Oncology
Payers
PBMs
Physicians
Rebranding
REMS
Sales Force